Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Comorbidities and Events of Clinical Interest in Patients with Pulmonary Arterial Hypertension (PAH): Analysis of Real-World Data.
Journal: Pulmonary circulation
Published: October 22, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Journal: The New England journal of medicine
Published: September 30, 2025
Pericardial effusion in sotatercept phase 3 trials: insights from STELLAR and ZENITH.
Journal: The European respiratory journal
Published: April 10, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
Journal: The New England journal of medicine
Published: April 01, 2025
The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension.
Journal: Clinical pharmacology and therapeutics
Published: September 28, 2023
Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers.
Journal: Clinical and translational science
Published: December 20, 2018
A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A/F nanobody, in moderate-to-severe psoriasis.
Journal: Journal of the American Academy of Dermatology
Published: December 18, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026